Adverum Biotechnologies, Inc. (ADVM) Ownership

$4.26

$0.09 (2.16%)
Last update: 04:00 PM EST
Day's range
$4.15
Day's range
$4.28

Adverum Biotechnologies, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
BML CAPITAL MANAGEMENT, LLC 11/10/2025 3.06 M $13.85 M   0.00% 14.55%
FRAZIER LIFE SCIENCES MANAGEMENT, L.P. 11/14/2025 2.08 M $9.41 M   94.29% 9.89%
TCG CROSSOVER MANAGEMENT, LLC 11/17/2025 1.67 M $7.56 M   -7.14% 7.94%
VANGUARD GROUP INC 11/07/2025 872.04 K $3.95 M   -1.35% 4.15%
5AM VENTURE MANAGEMENT, LLC 11/14/2025 541.67 K $2.45 M   0.00% 2.58%
GOLDMAN SACHS GROUP INC 11/14/2025 402.58 K $1.82 M   -19.04% 1.92%
RENAISSANCE TECHNOLOGIES LLC 11/13/2025 363.50 K $1.65 M   -36.30% 1.73%
PALE FIRE CAPITAL SE 11/13/2025 363.28 K $1.65 M   1.27% 1.73%
MILLENNIUM MANAGEMENT LLC 11/14/2025 324.42 K $1.47 M   -5.23% 1.54%
BLACKROCK, INC. 11/12/2025 311.39 K $1.41 M   -24.87% 1.48%
SOLEUS CAPITAL MANAGEMENT, L.P. 11/14/2025 287.25 K $1.30 M   0.00% 1.37%
DIMENSIONAL FUND ADVISORS LP 11/12/2025 234.54 K $1.06 M   -18.01% 1.12%
GEODE CAPITAL MANAGEMENT, LLC 11/12/2025 184.76 K $837.32 K   0.00% 0.88%
REGENERON PHARMACEUTICALS, INC. 11/07/2025 180.91 K $819.52 K   0.00% 0.86%
WAVERLY ADVISORS, LLC 11/14/2025 160.99 K $729.29 K   0.26% 0.77%
TWO SIGMA INVESTMENTS, LP 11/14/2025 88.67 K $401.68 K   372.73% 0.42%
STATE STREET CORP 11/14/2025 68.73 K $311.37 K   -0.13% 0.33%
QUINN OPPORTUNITY PARTNERS LLC 11/13/2025 41.42 K $187.62 K   0.00% 0.20%
TWO SIGMA ADVISERS, LP 11/14/2025 38.07 K $172.46 K   256.44% 0.18%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 11/14/2025 31.20 K $141.34 K   100.00% 0.15%
MARSHALL WACE, LLP 11/13/2025 28.37 K $128.50 K   -42.84% 0.14%
NORTHERN TRUST CORP 11/14/2025 28.06 K $127.10 K   -18.41% 0.13%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 11/14/2025 26.26 K $118.94 K   -55.66% 0.13%
CITADEL ADVISORS LLC 11/14/2025 24.10 K $109.17 K   100.00% 0.11%
QUBE RESEARCH & TECHNOLOGIES LTD 11/14/2025 21.73 K $98.44 K   -29.17% 0.10%
MORGAN STANLEY 11/14/2025 17.56 K $79.53 K   -66.84% 0.08%
CITADEL ADVISORS LLC 11/14/2025 17.27 K $78.22 K   -77.94% 0.08%
D. E. SHAW & CO., INC. 11/14/2025 17.15 K $77.70 K   -35.88% 0.08%
ROYAL BANK OF CANADA 11/14/2025 13.47 K $61.00 K   386.28% 0.06%
VANGUARD PERSONALIZED INDEXING MANAGEMENT, LLC 10/31/2025 12.81 K $58.01 K   100.00% 0.06%
XTX TOPCO LTD 11/14/2025 12.66 K $57.33 K   -57.47% 0.06%
SQUAREPOINT OPS LLC 11/14/2025 11.27 K $51.06 K   -47.94% 0.05%
UBS GROUP AG 11/13/2025 5.59 K $25.30 K   -60.59% 0.03%
BANK OF AMERICA CORP /DE/ 11/14/2025 3.61 K $16.37 K   -91.24% 0.02%
FMR LLC 11/13/2025 1.93 K $8.76 K   -16.82% 0.01%
ADVISOR GROUP HOLDINGS, INC. 11/14/2025 1.69 K $7.69 K   0.00% 0.01%
JONES FINANCIAL COMPANIES LLLP 11/04/2025 1.00 K $4.51 K   0.00% 0.00%
BNP PARIBAS ARBITRAGE, SNC 11/13/2025 540 $2.45 K   -31.30% 0.00%
PHYSICIAN WEALTH ADVISORS, INC. 11/04/2025 217 $984   100.00% 0.00%
JPMORGAN CHASE & CO 11/26/2025 182 $824   100.00% 0.00%
ALLWORTH FINANCIAL LP 12/02/2025 102 $463   0.00% 0.00%
SBI SECURITIES CO., LTD. 11/05/2025 84 $381   0.00% 0.00%
PARALLEL ADVISORS, LLC 11/13/2025 50 $227   0.00% 0.00%
WELLS FARGO & COMPANY/MN 11/13/2025 30 $136   -85.98% 0.00%
BARCLAYS PLC 11/12/2025 21 $96   100.00% 0.00%
GHP INVESTMENT ADVISORS, INC. 10/31/2025 20 $91   0.00% 0.00%
SRS CAPITAL ADVISORS, INC. 11/14/2025 19 $86   100.00% 0.00%
DEUTSCHE BANK AG\ 11/13/2025 1 $5   0.00% 0.00%
SOUND INCOME STRATEGIES, LLC 10/10/2025 1 $5   100.00% 0.00%
RAYMOND JAMES FINANCIAL INC 11/14/2025 0 $0   -100.00% 0.00%

Adverum Biotechnologies, Inc. institutional Ownership - FAQ's

During the previous two years, 96 institutional investors and hedge funds held shares of Adverum Biotechnologies, Inc.. The most heavily invested institutionals were:

BML Capital Management, LLC: 3.06 M

Frazier Life Sciences Management, L.P.: 2.08 M

TCG Crossover Management, LLC: 1.67 M

VANGUARD GROUP INC: 872,041

5AM Venture Management, LLC: 541,666

GOLDMAN SACHS GROUP INC: 402,581

54.68% of Adverum Biotechnologies, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 31.54 M shares in the last 24 months. This purchase volume represents approximately $134.38 M in transactions.